MicroRNA-214 exerts a Cardio-protective effect by inhibition of fibrosis

Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice

(2015) Hikari Okada et al.   CANCER SCIENCE

MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2

(2013) Tao Yang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MicroRNAs Involved in the Regulation of Postischemic Cardiac Fibrosis

(2013) Yao Dai et al.   HYPERTENSION

MicroRNA-214 Protects Cardiac Myocytes Against H2O2-Induced Injury

(2013) Guangwei Lv et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

MicroRNA-214 Antagonism Protects against Renal Fibrosis

(2013) L. Denby et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Up-regulation of miR-26a promotes apoptosis of hypoxic rat neonatal cardiomyocytes by repressing GSK-3β protein expression

(2012) Jong Hui Suh et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases

(2012) Bhoomika M. Patel et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Immunohistochemical detection of differentially localized up-regulation of lysyl oxidase and down-regulation of matrix metalloproteinase-1 in rhesus monkey model of chronic myocardial infarction

(2012) Yuping Xie et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death

(2012) Arin B. Aurora et al.   JOURNAL OF CLINICAL INVESTIGATION

Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes

(2011) Ji Fang et al.   APOPTOSIS

Renin-Angiotensin-Aldosterone Blockade for Cardiovascular Disease Prevention

(2011) Krishnaswami Vijayaraghavan et al.   CARDIOLOGY CLINICS

Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts

(2011) Li Li et al.   CARDIOVASCULAR RESEARCH

Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2

(2010) Zhenwei Pan et al.   BRITISH JOURNAL OF PHARMACOLOGY

Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart

(2010) E. E. Creemers et al.   CARDIOVASCULAR RESEARCH

Stimulation of Reactive Oxygen Species and Collagen Synthesis by Angiotensin II in Cardiac Fibroblasts

(2010) Paul J. Lijnen et al.   Cardiovascular Therapeutics

Role of MicroRNAs in Cardiac Preconditioning

(2010) Fadi N Salloum et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Targeting the ACE2–Ang-(1–7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure

(2010) Michikado Iwata et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Mammalian microRNAs predominantly act to decrease target mRNA levels

(2010) Huili Guo et al.   NATURE

Declining mortality following acute myocardial infarction in the Department of Veterans Affairs Health Care System

(2009) Stephan D Fihn et al.   BMC Cardiovascular Disorders

Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro

(2009) Le Yang et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

MicroRNA Expression Signature and the Role of MicroRNA-21 in the Early Phase of Acute Myocardial Infarction

(2009) Shimin Dong et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inhibition of Superoxide Dismutase Induces Collagen Production in Cardiac Fibroblasts

(2008) P. Lijnen et al.   AMERICAN JOURNAL OF HYPERTENSION

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

(2008) E. van Rooij et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA